当前位置: X-MOL 学术Eur. J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity
European Journal of Medicinal Chemistry ( IF 6.0 ) Pub Date : 2018-03-21 , DOI: 10.1016/j.ejmech.2018.03.049
Li Zhang , Jingyun Zhao , Beichen Zhang , Tao Lu , Yadong Chen

A series of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives were designed, synthesized and evaluated for their biological activity. Most of these compounds showed potent activities against c-Met kinase and cell growth inhibition. The most promising compound, 7d, has the IC50 values of 2.02 and 88 nM to inhibit c-Met kinase activity and cell growth in the MKN45 cell line, respectively. In addition, 7d is highly selective to c-Met and exhibits over 2500-fold selective inhibition to 16 tyrosine kinases evaluated.



中文翻译:

[1,2,4]三唑并[3,4-b] [1,3,4]噻二唑衍生物的发现:新型,有效和选择性的c-Met激酶抑制剂:合成,SAR研究和生物学活性

设计,合成了一系列[1,2,4]三唑并[3,4-b] [1,3,4]噻二唑衍生物,并对其生物学活性进行了评估。这些化合物大多数显示出对c-Met激酶有效的活性和对细胞生长的抑制作用。最有前途的化合物7d的IC 50值为2.02和88 nM,分别抑制c-Met激酶活性和MKN45细胞系中的细胞生长。此外,7d对c-Met具有高度选择性,对所评估的16种酪氨酸激酶表现出超过2500倍的选择性抑制。

更新日期:2018-03-21
down
wechat
bug